Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramy Ibrahim

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Cureus|August 22, 2022
Superior Vena Cava Syndrome Due to Right Anterior Mediastinal Hematoma: A Case ReportRamy Ibrahim, Swarada Yadav, Sumaita Waqar, et al.
Thrombosis Journal|August 8, 2017
Paget-Schroetter syndrome in the absence of common predisposing factors: a case reportRamy Ibrahim, Irina Dashkova, Myia Williams, et al.
Medical Oncology (Northwood, London, England)|July 2, 2010
Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapyKaan Harmankaya, Christa Erasim, Claus Koelblinger, et al.
Cancer Immunology, Immunotherapy : CII|September 20, 2014
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?Luana Calabrò, Giovanni Luca Ceresoli, Alessandra di Pietro, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 24, 2021
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundationMichele Maio, Michael Lahn, Anna Maria Di Giacomo, et al.
Clinical Medicine Insights. Blood Disorders|December 17, 2014
Idiopathic thrombocytopenia with iron deficiency anemiaRamy Ibrahim, Jaffar Ahmad Alhilli, Tyler T Cooper, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncologyAnna Maria Di Giacomo, Alessia Covre, Gianluca Giacobini, et al.
Seminars in Oncology|November 16, 2010
Development of ipilimumab: contribution to a new paradigm for cancer immunotherapyAxel Hoos, Ramy Ibrahim, Alan Korman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody)Mojtaba Akhtari, Edmund K Waller, David L Jaye, et al.
Clinical Medicine Insights. Case Reports|April 12, 2012
Triad of iron deficiency anemia, severe thrombocytopenia and menorrhagia-a case report and literature reviewRamy Ibrahim, Areej Khan, Shahzad Raza, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Cureus|August 22, 2022
Superior Vena Cava Syndrome Due to Right Anterior Mediastinal Hematoma: A Case ReportRamy Ibrahim, Swarada Yadav, Sumaita Waqar, et al.
Thrombosis Journal|August 8, 2017
Paget-Schroetter syndrome in the absence of common predisposing factors: a case reportRamy Ibrahim, Irina Dashkova, Myia Williams, et al.
Medical Oncology (Northwood, London, England)|July 2, 2010
Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapyKaan Harmankaya, Christa Erasim, Claus Koelblinger, et al.
Cancer Immunology, Immunotherapy : CII|September 20, 2014
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?Luana Calabrò, Giovanni Luca Ceresoli, Alessandra di Pietro, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 24, 2021
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundationMichele Maio, Michael Lahn, Anna Maria Di Giacomo, et al.
Clinical Medicine Insights. Blood Disorders|December 17, 2014
Idiopathic thrombocytopenia with iron deficiency anemiaRamy Ibrahim, Jaffar Ahmad Alhilli, Tyler T Cooper, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncologyAnna Maria Di Giacomo, Alessia Covre, Gianluca Giacobini, et al.
Seminars in Oncology|November 16, 2010
Development of ipilimumab: contribution to a new paradigm for cancer immunotherapyAxel Hoos, Ramy Ibrahim, Alan Korman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody)Mojtaba Akhtari, Edmund K Waller, David L Jaye, et al.
Clinical Medicine Insights. Case Reports|April 12, 2012
Triad of iron deficiency anemia, severe thrombocytopenia and menorrhagia-a case report and literature reviewRamy Ibrahim, Areej Khan, Shahzad Raza, et al.
Pageof 5